GUSHENGTANG (02273) intends to acquire 70% equity of Jinan Xinyang, Jinan Yunshengtang, and Jinan Licheng Yunshengtang.

GUSHENGTANG (02273) announced that on March 3, 2026, the company's subsidiary, Shandong GUSHENGTANG Health Technology Co., Ltd., intends to acquire 70% equity of Jinan Xinyang, 70% equity of Jinan Yunshengtang, and 70% equity of Jinan Licheng Yunshengtang. The target companies are all medical institutions mainly engaged in providing traditional Chinese medicine services and retailing medicine in Shandong Province, China. The acquisition is in line with the group's expansion strategy of increasing its offline medical institution network through acquisitions, with the belief that the acquisition will (i) increase the group's market share in Shandong Province, China, and (ii) create synergies between the target companies and the group's other offline medical institutions and online medical platforms.